Deedra Nicolet

Alliance Data (United States) — United States

Medicine · Health Sciences

36h-index4.9kcitations212works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(158), Myeloproliferative Neoplasms: Diagnosis and Treatment(41), Chronic Myeloid Leukemia Treatments(32), Protein Degradation and Inhibitors(27), Acute Lymphoblastic Leukemia research(25)

Publications212 total

Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia
JCI Insight·2026Open Access
Post-Transplant Outcomes in Older Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with VEN/HMA vs 7+3: A Real-World, Multicenter Analysis From the MARROW Consortium
Transplantation and Cellular Therapy·2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemias
Blood·2026
Supplementary Figures from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2026Open Access
Supplementary Tables from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2026Open Access
Real‐world analysis of <scp>CPX</scp> ‐351 in <scp>AML</scp> ‐ <scp>MR</scp> : A multicentre study from the <scp>MARROW</scp> consortium
British Journal of Haematology·2025Open Access
A multicenter real-world study on response and survival in older patients with acute myeloid leukemia treated with intensive chemotherapy versus VEN/HMA by 2022 and 2024 ELN risk stratifications: An analysis from the MARROW consortium
Blood·2025Open Access
Loss of the Y chromosome defines a biologically distinct subtype of Acute Myeloid Leukemia (AML), associated with decreased inflammatory response patterns, and favorable outcomes in young male patients (pts)
Blood·2025
Treatment responses and survival of newly diagnosed older or unfit patients (pts) with IDH1/2-mutated Acute Myeloid Leukemia (AML): An analysis of the MARROW consortium
Blood·2025
Accounting for long-term survivors and population-expected survival improves survival outcomes estimation and prediction in older patients with core-binding factor (CBF) Acute Myeloid Leukemia (AML)
Blood·2025Open Access
Defining the clinical characteristics and outcomes of adult patients (pts) with 11q23/KMT2A-rearranged Acute Myeloid Leukemia (AML): An analysis from the MARROW consortium
Blood·2025Open Access
Tri-partied analyses define clinical outcomes and molecular features of patients (pts) with acute promyelocytic leukemia (APL)
Blood·2025
Evaluation of cytarabine consolidation dosing in older adult patients with Acute Myeloid Leukemia
Blood·2025
Characteristics and clinical outcomes of patients (pts) with Acute Myeloid Leukemia (AML) with Mecom rearrangements: An analysis from the MARROW consortium
Blood·2025Open Access
Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid Leukemia
2025Open Access
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group &amp; Alliance for Clinical Trials in Oncology)
Leukemia·2025· 1 citedOpen Access
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
Blood Cancer Discovery·2025· 1 citedOpen Access
Figure 1 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025Open Access
Data from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025Open Access
Figure 3 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025Open Access
page 1 of 11Next →

Frequent Co-authors

Krzysztof Mrózek(42), Jessica Kohlschmidt(37), Jonathan E. Kolitz(37), Clara D. Bloomfield(36), Bayard L. Powell(33), Richard M. Stone(32), Andrew J. Carroll(31), John C. Byrd(27), Ann‐Kathrin Eisfeld(23), Guido Marcucci(19), James S. Blachly(19), Christopher J. Walker(17), Sebastian Schwind(16), Shelley Orwick(16), Ramiro Garzon(15), Heiko Becker(14), Klaus H. Metzeler(14), Maria R. Baer(14), Michael A. Caligiuri(14), Susan P. Whitman(13)